Skip to main content
Celemics, Inc. logo

Celemics, Inc. — Investor Relations & Filings

Ticker · 331920 ISIN · KR7331920009 KO Manufacturing
Open in API
Filings indexed 179 across all filing types
Latest filing 2024-03-21 Audit Report / Informat…
Country KR South Korea
Listing KO 331920

About Celemics, Inc.

https://www.celemics.com/

Celemics, Inc. is a biotechnology company that develops and provides Next-Generation Sequencing (NGS) solutions for research and clinical applications. The company specializes in hybridization-based target enrichment technology, offering a comprehensive portfolio of products and services. This includes ready-to-use and customized NGS panels, whole exome sequencing kits, library preparation kits, modular accessories, and bioinformatics analysis services. Celemics' solutions support a wide range of fields, including oncology (somatic cancer, liquid biopsy), inherited diseases, pathogen analysis, pharmacogenomics, and immune repertoire profiling. A key focus is the development of end-to-end customized target enrichment panels, providing support from assay design and optimization to complete bioinformatics analysis. The company's proprietary technologies in probe design and molecular barcoding enable efficient analysis of diverse and challenging sample types.

Recent filings

Filing Released Lang Actions
사업보고서 (2023.12)
Audit Report / Information Classification · 1% confidence The document is a formal 'Audit Report' (감사보고서) for the company 'Celemix' (주식회사 셀레믹스) for the fiscal year ending December 31, 2023. It includes the independent auditor's opinion, financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes to the financial statements. This is a comprehensive financial reporting document, not an earnings release or a simple announcement, and it is distinct from a full 10-K annual report which typically includes management discussion and analysis (MD&A) and business descriptions. Therefore, it is classified as an Audit Report. FY 2023
2024-03-21 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a regulatory filing from a Korean company (Celemix) titled 'Audit Report Submission' (감사보고서 제출). It provides a summary of financial data, audit opinions, and key financial metrics (assets, liabilities, profit/loss) for the current and previous fiscal years. According to the 'Menu vs Meal' rule, this is an announcement of the audit report submission rather than the full, multi-page audit report document itself. In the context of Korean regulatory filings (DART system), this specific format is classified as a Report Publication Announcement (RPA) as it notifies the market that the audit report has been submitted. FY 2023
2024-03-20 Korean
[기재정정]주주총회소집공고
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a 'Notice of Convocation of the Annual General Meeting' (주주총회소집공고) for Celemics. It contains the agenda for the meeting, including the approval of financial statements, director appointments, and remuneration limits. It also includes detailed financial statements (balance sheet, income statement, etc.) as part of the management's reporting for the AGM. This document is a standard proxy statement/notice for an upcoming shareholder meeting, which falls under the 'Proxy Solicitation & Information Statement' category.
2024-03-06 Korean
주주총회소집결의
AGM Information Classification · 1% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for the company Celemix. It outlines the date, time, location, and the agenda items (financial statement approval, director appointment, and remuneration limits). This document is a standard proxy solicitation material used to inform shareholders of an upcoming meeting and the matters to be voted upon, which fits the definition of Proxy Solicitation & Information Statement (PSI).
2024-03-04 Korean
주주총회집중일개최사유신고
AGM Information Classification · 1% confidence The document is a formal regulatory filing submitted to the KRX (Korea Exchange) regarding the scheduling of a General Meeting of Shareholders on a 'concentrated day' (a date when many companies hold their AGMs). It explains the reason for the scheduling conflict and provides the meeting date. Since this is a regulatory disclosure regarding meeting logistics rather than the meeting materials themselves or a proxy statement, it falls under the general regulatory filing category.
2024-03-04 Korean
주주총회소집공고
AGM Information Classification · 1% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Celemics, which includes the agenda, director candidate information, and financial statements (audit-preliminary) for the 14th fiscal year. This document is a formal proxy statement and information package provided to shareholders to solicit votes for the upcoming Annual General Meeting. According to the filing definitions, this fits the 'Proxy Solicitation & Information Statement' (PSI) category, as it contains the meeting notice, agenda items, and supporting information for shareholder voting.
2024-03-04 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.